These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7167609)

  • 21. Ego strength denial on the MMPI-2 as a clue to simulation of personal injury in vocational neuropsychological and emotional distress evaluations.
    Lees-Haley PR
    Percept Mot Skills; 1991 Jun; 72(3 Pt 1):815-9. PubMed ID: 1891319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further validation of the MMPI-2 and MMPI-2-RF Response Bias Scale: findings from disability and criminal forensic settings.
    Wygant DB; Sellbom M; Gervais RO; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Psychol Assess; 2010 Dec; 22(4):745-56. PubMed ID: 20919770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
    Gray O; McDonnell G; Hawkins S
    Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The work capacity of patients with disseminated sclerosis].
    Ierusalimskiĭ AP; Kuriachenko IuT
    Sov Med; 1988; (3):55-7. PubMed ID: 3413551
    [No Abstract]   [Full Text] [Related]  

  • 25. Perfectionism and physical disability predict depression in multiple sclerosis.
    Smith MM; Arnett PA
    J Psychosom Res; 2013 Aug; 75(2):187-9. PubMed ID: 23915778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of neuropsychological alterations in multiple sclerosis.
    Bertrando P; Maffei C; Ghezzi A
    Acta Psychiatr Belg; 1983; 83(1):13-21. PubMed ID: 6613610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: a known-groups study.
    Bianchini KJ; Etherton JL; Greve KW; Heinly MT; Meyers JE
    Assessment; 2008 Dec; 15(4):435-49. PubMed ID: 18539782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Multiple Sclerosis Self-Management Scale: revision and psychometric analysis.
    Bishop M; Frain MP
    Rehabil Psychol; 2011 May; 56(2):150-9. PubMed ID: 21574735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological stability in multiple sclerosis.
    Ivnik RJ
    J Consult Clin Psychol; 1978 Oct; 46(5):913-23. PubMed ID: 701571
    [No Abstract]   [Full Text] [Related]  

  • 31. Personality characteristics of three disability groups.
    Bourestom NC; Howard MT
    Arch Phys Med Rehabil; 1965 Sep; 46(9):626-32. PubMed ID: 4378524
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychological and physical predictors of illness intrusiveness in patients with multiple sclerosis.
    Snyder S; Foley FW; Farrell E; Beier M; Zemon V
    J Neurol Sci; 2013 Sep; 332(1-2):41-4. PubMed ID: 23849841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis.
    Ayatollahi P; Nafissi S; Eshraghian MR; Kaviani H; Tarazi A
    Mult Scler; 2007 Mar; 13(2):275-7. PubMed ID: 17439899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMPI indicators of treatment response to spinal epidural stimulation in patients with chronic pain and patients with movement disorders.
    Brandwin MA; Kewman DG
    Psychol Rep; 1982 Dec; 51(3 Pt 2):1059-64. PubMed ID: 6220420
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessing the prevalence of cognitive impairment in multiple sclerosis: implications for patient management.
    Penman MF
    Axone; 1991 Dec; 13(2):45-9. PubMed ID: 1764408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing the health-related quality of life in Hungarian multiple sclerosis patients.
    Füvesi J; Bencsik K; Losonczi E; Fricska-Nagy Z; Mátyás K; Mészáros E; Benedek K; Rajda C; Lencsés G; Vécsei L
    J Neurol Sci; 2010 Jun; 293(1-2):59-64. PubMed ID: 20394948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experiences with psychosocial management of patients with multiple sclerosis in a discussion group].
    Paris C
    Psychiatr Neurol Med Psychol (Leipz); 1990 Jul; 42(7):426-9. PubMed ID: 2236354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the International Classification of Functioning, Disability and Health to describe patient-reported disability: a comparison of Guillain Barré syndrome with multiple sclerosis in a community cohort.
    Khan F; Amatya B; Ng L
    J Rehabil Med; 2010 Sep; 42(8):708-14. PubMed ID: 20809051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the MMPI with multiple personality patients.
    Solomon R
    Psychol Rep; 1983 Dec; 53(3 Pt 1):1004-6. PubMed ID: 6657827
    [No Abstract]   [Full Text] [Related]  

  • 40. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
    Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
    Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.